The use of Artificial Intelligence (AI) has had a tremendous impact on nearly every industry over the last several years. The promise AI holds for organizations to decrease the costs, while increasing the speed and accuracy associated with core and secondary activities has driven significant investments. Our panel of experts share how artificial intelligence is set to change the drug lifecycle, with a particular focus on the impact to business development and licensing and regulatory affairs.
Fill out the form at the right to watch now.